4Zannad F, AIla F, Dousser B, et al. For RALES Investigators. Limita tion of extracelleular matrix turnover may contribute to survival benefit of spironolaetone therapy in patients with congestive heart failure[J].Circulation, 2000,102 : 2700 - 2706.
5Rocha R,Williams GH. Rationale for the use of aldosterone antag- onists in congestive heart failure[J].Drugs, 2002 (62) : 723 - 731.
6Pitt B, Zannad F, Remme WJ,et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure[J]. N Engl J Med,1999(34,1) :709 - 717.
7Maisel AS, Krishnaswamy P, Nowak RM,et al. Rapid measure of B- type natriuretic poptied in the emergency diagnosis of heart failure[J]. N Engl J Med,2002,347(3) :161 - 167.
8Macdonald JE, Kennedy N, Struthers AD. Effects of spironolactone on endothelial function , vascular angiotensin converting enzyme activity,and other prognostic markers in patients with mild heart failure already taking optimal treatment[J]. Heart, 2004,90 : 765 - 770.
9俞锋.心肌病诊治若干进展[J].心功能杂志,1999,11:16-16.
10Williams JS, Williams GH. 50th anniversary of aldosterone [ J]. J Clin Endocrinol Metab,2003,88(6) :2364-2372
1Butler JV, McAvoy H, McEnroy D, MulkerrinEC. Spironolactone therapy in older patients-the impact of renaldysfunction[J]. Archives of Gerontology and Geriatrics, 2002,35(1):45-49.
2Cruz CS, Cruz AA, Marcilio de Souza CA. Hyperkalaemia incongestive heart failure patients using ACE inhibitors andspironolactone[J]. Nephrology, dialysis, transplantation, 2003,18(9):1814-1819.
3Cicoira Mariantonietta, Zanolla Luisa, Rossi Andrea, GoliaGiorgio, Franceschini Lorenzo, Brighetti Giovanna, MarinoPaolo, Zardini Piero.Long-term, dose-dependent effects ofspironolactone on left ventricular function and exercisetolerance in patients with chronic heart failure[J]. Journal ofthe American College of Cardiology, 2002,40 (2) : 304-310.
4Ferreira JP, Santos M, Almeida S,et al.The role of albu- minutia as a non-invasive marker for congestive acutely decompensated chronic heart failure and the spironolac- tone effect in elderly Portuguese:a non-randomized trial[J]. Nephrology (C arhon ), 2014,19 (3) : 149-156.
5Ogino K,Kinugasa Y,Kato M,et al.Spironolactone,not furo- semide,improved insulin resistance in patients with chron- ic heart failure[J].Im J Cardiol,2014,171 (3) :398-403.
6Eng M,Bansal S.Use of natriuretic-doses of spironolactone for treatment of loop diuretic resistant acute decompen- sated heart failure[J].Int J Cardiol,2014,170(3) :e68-e69.
